Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 189, Issue 8, Pages 1452-1465Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/382488
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI43222, AI51178] Funding Source: Medline
- PHS HHS [T32A107291, F32A1056696] Funding Source: Medline
Ask authors/readers for more resources
Human immunodeficiency virus (HIV) production continues in patients receiving highly active antiretroviral therapy (HAART) with undetectable (<50 copies/mL) virus loads. Our initial cross-sectional study showed that this viremia is composed of viruses that lack new resistance mutations to the HAART regimen. Here we describe a longitudinal, clonal genotypic analysis of plasma virus loads in treated adults who had undetectable virus loads. We document a continuous production of virus in 8 HIV-1-infected adults who maintained suppression of viremia for up to 15 months. Using analytical approaches for distinguishing selected resistance mutations from nonselected mutations and polymerase chain reaction errors, we detected no evolution of resistance in the reverse-transcriptase and protease genes. Sporadic resistance mutations were detected in some viral clones that were not selected for subsequently. Thus, in some patients, HAART suppresses replication to a level that does not allow the evolution of drug resistance over a time frame of years.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available